Hépato-Gastro & Oncologie Digestive
Volume 19, issue 4, Avril 2012
Volume 19, issue 4, Avril 2012
Éditorial
Immunosuppressive therapy and cancers in inflammatory bowel disease or how to take into account the benefit-risk ratio in our clinical practice?
(p.227-9)
Laurent Peyrin-Biroulet
Free Access
Mini-revue
Radioembolization of primary and secondary liver tumors
(p.231-8)
Olivier Dubreuil, Aziz Zaanan, Isabelle Trouilloud, Marc Sapoval, Olivier Pellerin, Sameh Awad, Nadia Ghazzar, Céline Lepère, Philippe Rougier, Julien Taieb
Free Access
MSI colon cancer: is adjuvant therapy warranted?
(p.242-7)
Aziz Zaanan, Olivier Dubreuil, Isabelle Trouilloud, Pierre Laurent-Puig, Julien Taieb
Free Access
Evolution of practices and factual results of liver transplantation for alcoholic liver disease
(p.248-53)
Amélie Cannesson, Guillaume Lassailly, Emmanuel Boleslawski, Alexandre Louvet, Philippe Mathurin, François René Pruvot, Sébastien Dharancy
Free Access
Clinical implications of diabetes mellitus in cirrhosis
(p.254-62)
Pauline Houssel, Richard Moreau, Laure Elkrief
Free Access
Dyschezia: from diagnostic to treatment
(p.263-71)
Véronique Vitton, Henri Damon, Jean-Luc Faucheron
Free Access
Screening of biliary and liver diseases in inflammatory bowel disease. Consequences on the therapeutic management
(p.272-9)
Stéphane Nancey, Gilles Boschetti, Bernard Flourié
Free Access
Concepts et Pratique
Acute severe alcoholic hepatitis: good news from France!
(p.280-4)
Alexandre Pariente
Free Access
Fecal tranplantation: new therapy for recurrent Clostridium difficile infection?
(p.285-8)
Frédérique Maire
Free Access
Infos-PRO
Une loi de circonstance
(p.289-90)
Philippe Godeberge
Free Access
Agenda
Agenda
(p.291-2)
Free Access
Injections de rappel
Injections de rappel
(p.293-4)
Free Access